Log in to save to my catalogue

The Clinical Effectiveness of Single-Dose Human Papillomavirus Vaccination

The Clinical Effectiveness of Single-Dose Human Papillomavirus Vaccination

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_doaj_primary_oai_doaj_org_article_7fd26ecc92fe442294d4cbd284976bc4

The Clinical Effectiveness of Single-Dose Human Papillomavirus Vaccination

About this item

Full title

The Clinical Effectiveness of Single-Dose Human Papillomavirus Vaccination

Publisher

Switzerland: MDPI AG

Journal title

Vaccines (Basel), 2024-09, Vol.12 (9), p.956

Language

English

Formats

Publication information

Publisher

Switzerland: MDPI AG

More information

Scope and Contents

Contents

The human papillomavirus (HPV) vaccine was initially approved for a three-dose regimen. Due to resource limitations, budget constraints, low acceptance, and poor adherence, global vaccination coverage is only 15%. A single-dose regimen could simplify logistics, reduce costs, and improve accessibility. However, its clinical effectiveness remains deb...

Alternative Titles

Full title

The Clinical Effectiveness of Single-Dose Human Papillomavirus Vaccination

Authors, Artists and Contributors

Identifiers

Primary Identifiers

Record Identifier

TN_cdi_doaj_primary_oai_doaj_org_article_7fd26ecc92fe442294d4cbd284976bc4

Permalink

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_doaj_primary_oai_doaj_org_article_7fd26ecc92fe442294d4cbd284976bc4

Other Identifiers

ISSN

2076-393X

E-ISSN

2076-393X

DOI

10.3390/vaccines12090956

How to access this item